Outlook Therapeutics (OTLK) Cash from Investing Activities Growth (1y) (2016 - 2019)
Outlook Therapeutics (OTLK) Cash from Investing Activities Growth (1y) (2016 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
63.14 Mn |
55.40 Mn |
-21,888.00 |
- |
| Date | Value |
|---|
| Sep 30, 2019 |
100.00% |
| Jun 30, 2019 |
10.29% |
| Mar 31, 2019 |
81.78% |
| Dec 31, 2018 |
78.01% |
| Sep 30, 2018 |
-5,165.95% |
| Jun 30, 2018 |
-120.41% |
| Mar 31, 2018 |
-532.39% |
| Dec 31, 2017 |
-624.68% |
| Sep 30, 2017 |
92.70% |
| Jun 30, 2017 |
83.15% |
| Mar 31, 2017 |
-192.69% |
| Dec 31, 2016 |
59.27% |
| Sep 30, 2016 |
90.03% |
| Jun 30, 2016 |
87.03% |
